Pronađeno: 1-4 / 4 radova

Autori: McIntyre Christine

>> Filter: Samo Article i Review

>> Sve godine

Naslov Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study (Article)
Autori Davies Andrew Merli Francesco Mihaljevic Biljana S  Siritanaratkul Noppadol Solal-Celigny Phillippe Barrett Martin Berge Claude Bittner Beate Boehnke Axel McIntyre Christine MacDonald David 
Info LANCET ONCOLOGY, (2014), vol. 15 br. 3, str. 343-352
Projekat F Hoffmann-La Roche
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina Study (Meeting Abstract)
Autori Davies Andrew Merli Francesco Mihaljevic Biljana S  Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett Martin Macdonald David 
Info HAEMATOLOGICA, (2013), vol. 98 br. , Suppl. 1, str. 131-132
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicular lymphoma (FL) in the first-line setting: Stage 1 results of the phase III SABRINA study (Meeting Abstract)
Autori Davies AJ Merli Francesco Mihaljevic Biljana S  Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett M MacDonald D 
Info BRITISH JOURNAL OF HAEMATOLOGY, (2013), vol. 161 br. , Suppl. 1, str. 7-8
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334) (Meeting Abstract)
Autori Davies Andrew J Merli Francesco Mihaljevic Biljana S  Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett Martin Macdonald David 
Info BLOOD, (2012), vol. 120 br. 21, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX